Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
5.615 USD | +3.03% | +10.90% | -27.97% |
May. 14 | Transcript : Syros Pharmaceuticals, Inc., Q1 2024 Earnings Call, May 14, 2024 | |
May. 14 | Syros Pharmaceuticals, Inc. Agrees to Amend Its Loan Agreement with Oxford Finance LLC | CI |
Chart calendar Syros Pharmaceuticals, Inc.
Upcoming events on Syros Pharmaceuticals, Inc.
Past events on Syros Pharmaceuticals, Inc.
2024-05-14 11:00 am | Citizens JMP Life Sciences Conference |
2024-05-14 08:30 am | Q1 2024 Earnings Call |
2024-05-14 07:30 am | Q1 2024 Earnings Release |
2024-03-27 08:30 am | Q4 2023 Earnings Call |
2024-03-27 07:30 am | Q4 2023 Earnings Release |
2024-03-05 09:10 am | TD Cowen Health Care Conference |
2023-12-06 11:00 am | The JMP Securities Hemaology and Oncology Summit |
2023-12-06 08:30 am | SELECT-AML-1 Phase 2 Trial Results Call |
2023-11-28 02:00 pm | Piper Sandler Healthcare Conference |
2023-11-14 08:30 am | Q3 2023 Earnings Call |
2023-11-14 07:30 am | Q3 2023 Earnings Release |
2023-08-08 08:30 am | Q2 2023 Earnings Call |
2023-08-08 07:30 am | Q2 2023 Earnings Release |
2023-06-15 10:00 am | Sidoti Small-Cap Virtual Conference |
2023-06-03 09:00 am | American Society of Clinical Oncology Conference - Abstract No 3080 |
2023-06-03 09:00 am | American Society of Clinical Oncology Conference - Abstract No 3081 |
2023-06-01 09:00 am | Annual General Meeting |
2023-05-16 10:00 am | JMP Securities Life Sciences Conference |
2023-05-10 08:30 am | Q1 2023 Earnings Call |
2023-05-10 07:30 am | Q1 2023 Earnings Release |
Annual results
Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 1,98 2,16 -8.13% | 15,1 12,1 24.83% | 23,5 20,4 14.96% | 14,9 19,5 -23.56% | 9,94 11,5 -13.75% | 0,50 |
EBITDA | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
EBIT Million USD | Released Forecast Spread | -77,7 -79,0 1.57% | -82,3 -78,2 -5.28% | -99,4 -103 3.05% | -136 -125 -8.72% | -129 -138 6.54% | -121 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -75,4 -76,8 1.83% | -84,0 -79,3 -6.04% | -86,6 -94,1 8.03% | -94,7 -116 18.65% | -165 -136 -21.16% | -91,2 |
Net income Million USD | Released Forecast Spread | -75,4 -76,7 1.64% | -84,0 -78,9 -6.47% | -86,6 -94,5 8.38% | -94,7 -117 19.12% | -165 -135 -22.21% | -91,2 |
EPS USD | Released Forecast Spread | -18,8 -18,8 0.23% | -18,2 -17,0 -6.88% | -13,8 -15,1 8.52% | -7,49 -9,66 22.45% | -5,81 -4,73 -22.73% | -2,27 |
Announcement Date | 05/03/20 | 04/03/21 | 15/03/22 | 02/03/23 | 27/03/24 | - |
Quarterly results
Fiscal Period | December | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 5,47 4,92 11.12% | 6,28 4,78 31.21% | 3,89 4,85 -19.77% | -0,75 3,85 -119.58% | 2,95 3,30 -10.48% | 2,83 3,50 -19.06% | 3,76 3,94 -4.52% | 0,39 2,00 -80.7% | 0,00 0,72 - | 0,13 | 0,13 | 0,13 | 0,00 | 0,00 |
EBIT Million USD | Released Forecast Spread | -26,7 -29,4 9.19% | -33,8 -26,4 -27.87% | -39,5 -30,7 -28.52% | -36,0 -30,8 -16.86% | -33,2 -31,7 -4.77% | -34,0 -34,3 1% | -34,6 -35,0 1.16% | -27,1 -36,8 26.27% | -30,9 -27,8 -11.33% | -29,5 | -29,7 | -33,3 | -36,0 | -39,5 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -25,1 -29,6 15.05% | -34,5 -25,9 -33.13% | -30,3 -31,4 3.77% | -4,77 -30,3 84.23% | -23,8 -29,6 19.58% | -36,3 -31,5 -15.18% | -40,1 -31,9 -25.94% | -64,4 -35,6 -80.68% | -3,71 -29,8 87.54% | -29,4 | -29,8 | -33,4 | -36,5 | -40,1 |
Net income Million USD | Released Forecast Spread | -25,1 -29,6 15.05% | -34,5 -25,9 -33.13% | -30,3 -31,4 3.77% | -4,77 -30,3 84.23% | -23,8 -29,6 19.58% | -36,3 -31,5 -15.18% | -40,1 -31,9 -25.94% | -64,4 -35,6 -80.68% | -3,71 -29,8 87.54% | -29,4 | -29,8 | -33,4 | -36,5 | -40,1 |
EPS USD | Released Forecast Spread | -4,00 -4,70 14.89% | -5,40 -4,08 -32.35% | -3,21 -3,99 19.48% | -0,17 -1,30 86.91% | -0,85 -1,05 18.92% | -1,30 -1,13 -15.25% | -1,43 -1,14 -25.44% | -2,22 -1,14 -94.06% | -0,10 -0,87 88.51% | -0,78 | -0,79 | -0,89 | -0,92 | -1,00 |
Announcement Date | 16/05/22 | 09/08/22 | 14/11/22 | 02/03/23 | 10/05/23 | 08/08/23 | 14/11/23 | 27/03/24 | 14/05/24 | - | - | - | - | - |
2024-05-20 | ALVOTECH: Q1 2024 Earnings Release |
2024-05-21 07:00 am | EXSCIENTIA PLC: Q1 2024 Earnings Release |
2024-05-21 | CUREVAC N.V.: Q1 2024 Earnings Release (Projected) |
2024-05-21 | EVOTEC SE: Q1 2024 Earnings Release |
2024-06-30 | IMMUNOVANT, INC.: Q4 2024 Earnings Release (Projected) |
2024-07-15 01:45 am | ADDLIFE AB: Q2 2024 Earnings Release |
2024-07-21 | MEDPACE HOLDINGS, INC.: Q2 2024 Earnings Release (Projected) |
2024-07-23 | SYNGENE INTERNATIONAL LIMITED: Q1 2025 Earnings Release (Projected) |
2024-07-23 | ALKERMES PLC: Q2 2024 Earnings Release (Projected) |
2024-07-23 | IQVIA HOLDINGS INC.: Q2 2024 Earnings Release (Projected) |
Past sector events for Syros Pharmaceuticals, Inc.
2024-05-17 02:00 am | BIOARCTIC AB: Q1 2024 Earnings Release |
2024-05-15 04:05 pm | CULLINAN THERAPEUTICS, INC.: Q1 2024 Earnings Release |
2024-05-14 | GNI GROUP LTD.: Q1 2024 Earnings Release |
2024-05-14 04:05 pm | NUVATION BIO INC.: Q1 2024 Earnings Release |
2024-05-14 07:30 am | ABSCI CORPORATION: Q1 2024 Earnings Release |
2024-05-14 01:50 am | BELITE BIO, INC: Q1 2024 Earnings Release |
2024-05-13 | POLARIS GROUP: Q1 2024 Earnings Release |
2024-05-13 04:30 pm | AEROVATE THERAPEUTICS, INC.: Q1 2024 Earnings Release |
2024-05-13 07:00 am | APOGEE THERAPEUTICS, INC.: Q1 2024 Earnings Release |
2024-05-12 07:00 pm | PRAXIS PRECISION MEDICINES, INC.: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- SYRS Stock
- Calendar Syros Pharmaceuticals, Inc.